AgingResearch.NewsJoin free

Single-pill combination therapy

Single-pill combination therapy has been studied in 3 papers since 2026: 2 trials and 1 observational study in people; 3 in the past year. The newest story, Nov 9, 2026: “Combination-pill care program lowered blood pressure”.

Intervention

3 papers study it4 findingsUpdated

1 new paper in 30 daysSee all 3 papers on single-pill combination therapy

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

“SPC use was associated with 22% increased likelihood of achieving target BP by 6 months [odds ratio (95% confidence interval), 1.22 (1.05, 1.42)].”
Association between single-pill combination therapy use and blood pressure control in the Systolic Blood Pressure Reduction Intervention Trial: a post hoc analysisEuropean journal of preventive cardiology2026doi:10.1093/eurjpc/zwag043

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 2 independent labs in 2 countries
  • Funders: National Center for Advancing Translational Sciences and 4 more
  • 3 of 4 findings with company ties
  • Human trial2
  • Humans1

What did studies of single-pill combination therapy find?

3

Studies of single-pill combination therapy measured 3 outcomes; the most studied are cardiovascular events (1 study), blood pressure (1) and blood pressure control (1).

Cardiovascular events

no changein humans1

1 study

  1. Single-pill combination therapy showed no clear effect on cardiovascular events in humans.

    “The risk of the primary CV composite endpoint and SAEs were not significantly different between groups.”

    Human trial

    Association between single-pill combination therapy use and blood pressure control in the Systolic Blood Pressure Reduction Intervention Trial: a post hoc analysis

    European journal of preventive cardiology

More on Cardiovascular events

Blood pressure

downin humans1

1 study

  1. Single-pill combination therapy decreases blood pressure in humans (-2.0 vs. -1.2 mmHg monthly change; P-diff < 0.001).

    “Participants receiving SPCs (vs. multi-pills) experienced more rapid BP reduction in the first 6 months (-2.0 vs. -1.2 mmHg monthly change; P-diff < 0.001).”

    Human trial6 months

    Association between single-pill combination therapy use and blood pressure control in the Systolic Blood Pressure Reduction Intervention Trial: a post hoc analysis

    European journal of preventive cardiology

Blood pressure control

upin humans1OR 1.22

1 study

  1. Single-pill combination therapy improves blood pressure control in humans (OR 1.22 (95% CI 1.05, 1.42)).

    “SPC use was associated with 22% increased likelihood of achieving target BP by 6 months [odds ratio (95% confidence interval), 1.22 (1.05, 1.42)].”

    Human trial6 months

    Association between single-pill combination therapy use and blood pressure control in the Systolic Blood Pressure Reduction Intervention Trial: a post hoc analysis

    European journal of preventive cardiology

What acts on single-pill combination therapy?

1

Studies name 1 thing that act on single-pill combination therapy, most often case-specific guidance on spc therapy (1 study).

Case-specific guidance on spc therapy

upin humans1

1 study

  1. Case-specific guidance on spc therapy increases single-pill combination therapy in humans (hypertension) (25.1% vs. 9.6%, p<0.001).

    “SPC initiation was higher in the IC than US (25.1% vs. 9.6%, p<0.001).”

    Human trialhypertensionmedian follow-up of 367 daysn = 438

    SOLO study: A single-pill combination strategy in general practice to optimize blood pressure control in a multi-ethnic community

    medRxivPreprint

More on Case-specific guidance on spc therapy

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 13 papers in 12 months
JAMA

Combination-pill care program lowered blood pressure

The combined program reduced the upper blood pressure reading by 10.1 millimeters of mercury more than standard care over 18 months.The combined program reduced the upper blood pressure reading by 10.1 millimeters of mercury more than standard care over 18 months.

Randomized trial · 1,574 peopleHypertension
Paper

Related